Skip to main content
HighlightsHighlights Archive

Media Monitoring: 7th – 13th May

By May 13, 2022No Comments

Manchester-based research helps develop ovarian cancer blood test

  • The University of Manchester has stated that a novel blood test is extremely effective in diagnosing ovarian cancer, especially those under 50
  • Researchers investigated whether the human epididymis protein 4 (HE4), a protein type present in the blood, could help identify ovarian cancer more accurately
  • The test is very simple and is able to be given by GPs


Over 65,000 people wait longer than they should for cancer results each month
New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month

  • This data was gleaned from Faster Diagnosis Standard (FDS) – the performance standard introduced by Government in 2021
  • The current FDS target is 75% – meaning that at least 75% of people should receive their test results back within 28 days, however, that target has never been met


International siblings study provides fascinating clues as to the genetics of disease

  • A new study has shown that for social traits these genetic effects are due to a mixture of direct effects (e.g. biological effects of DNA), and indirect effects (e.g. family or social environment). Whereas biological traits are mainly driven by direct effect 


NHS Monthly Diagnostic Statistics

  • The total number of patients waiting six weeks or more from referral for one of the 15 key diagnostic tests at the end of March 2022 was 389,900. This was 24.8% of the total number of patients waiting at the end of the month
  • The estimated average time that a patient had been waiting for a diagnostic test was 3.1 weeks at the end of March 2022
  • A total of 2,079,300 diagnostic tests were undertaken in March 2022. This is an increase of 145,700 from March 2021
  • There were 1,568,500 patients waiting for a key diagnostic test at the end of March 2022. This is an increase of 313,000 from March 2021


Diverse global diabetes study sheds new light on the genetics of diabetes

  • The study ensured that almost 50% of participants were from non-white backgrounds to provide better data and tackle historic bias
  • DNA from millions of people with and without diabetes was analysed so that scientists could focus on the parts of the genome associated with disease risk


Swansea scientists develop method to detect viruses in tiny volumes

  • This follows a successful Innovate UK project to use graphene for use in biosensors
  • This would give many non-high tech hospitals and healthcare settings, or even point-of-care in challenging places, the ability to detect deadly viruses – saving millions each year worldwide
  • Graphene is able to pick up on miniscule disease marker levels and it is hoped that multiple biosensors can be put onto a single chip